Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Cheng Yang

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Foods (Basel, Switzerland)|February 13, 2025
Assessing Dietary Exposure Risk to Food Preservatives Among the Eating-Out Population in Taiwan Using the Total Diet Study MethodHao-Hsiang Ku, Shih-Cheng Yang, Huai-An Hsiao, et al.
Scientific Reports|December 8, 2020
The impact of aspirin on Klebsiella pneumoniae liver abscess in diabetic patientsChien-Hsiang Tai, Chien-Ning Hsu, Shih-Cheng Yang, et al.
The Journal of Antimicrobial Chemotherapy|April 27, 2013
Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutantsShih-Cheng Yang, Chuan-Mo Lee, Tsung-Hui Hu, et al.
Infection and Drug Resistance|November 23, 2018
Efficacy of a 14-day quadruple-therapy regimen for third-line <i>Helicobacter pylori</i> eradicationHsiang Tso Huang, Hsin-Ming Wang, Shih-Cheng Yang, et al.
Hepatology International|July 24, 2015
Combining the HBsAg decline and HBV DNA levels predicts clinical outcomes in patients with spontaneous HBeAg seroconversionShih-Cheng Yang, Sheng-Nan Lu, Chuan-Mo Lee, et al.
Journal of Gastroenterology and Hepatology|November 28, 2020
Risks of adverse events for users of proton-pump inhibitors plus aspirin or clopidogrel in patients with aspirin-related ulcer bleedingShih-Cheng Yang, Cheng-Kun Wu, Wei-Chen Tai, et al.
Medicine|July 19, 2016
Medical expenses in treating acute esophageal variceal bleeding: A 15-year nationwide population-based cohort studyChueh-Ling Liu, Cheng-Kun Wu, Hon-Yi Shi, et al.
Infectious Diseases and Therapy|May 3, 2023
The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled TrialWei-Chen Tai, Shih-Cheng Yang, Chih-Chien Yao, et al.
Therapeutic Advances in Gastroenterology|September 23, 2025
Comparative efficacy and safety of vonoprazan versus esomeprazole-based high-dose dual therapies for first-line <i>Helicobacter pylori</i> eradication: a randomized controlled trialWei-Chen Tai, Lung-Sheng Lu, Shih-Cheng Yang, et al.
Infection and Drug Resistance|June 17, 2021
Increased Risk of Pyogenic Liver Abscess after Endoscopic Sphincterotomy for Treatment of CholedocholithiasisCheng-Kun Wu, Chien-Ning Hsu, Wei-Ru Cho, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Foods (Basel, Switzerland)|February 13, 2025
Assessing Dietary Exposure Risk to Food Preservatives Among the Eating-Out Population in Taiwan Using the Total Diet Study MethodHao-Hsiang Ku, Shih-Cheng Yang, Huai-An Hsiao, et al.
Scientific Reports|December 8, 2020
The impact of aspirin on Klebsiella pneumoniae liver abscess in diabetic patientsChien-Hsiang Tai, Chien-Ning Hsu, Shih-Cheng Yang, et al.
The Journal of Antimicrobial Chemotherapy|April 27, 2013
Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutantsShih-Cheng Yang, Chuan-Mo Lee, Tsung-Hui Hu, et al.
Infection and Drug Resistance|November 23, 2018
Efficacy of a 14-day quadruple-therapy regimen for third-line <i>Helicobacter pylori</i> eradicationHsiang Tso Huang, Hsin-Ming Wang, Shih-Cheng Yang, et al.
Hepatology International|July 24, 2015
Combining the HBsAg decline and HBV DNA levels predicts clinical outcomes in patients with spontaneous HBeAg seroconversionShih-Cheng Yang, Sheng-Nan Lu, Chuan-Mo Lee, et al.
Journal of Gastroenterology and Hepatology|November 28, 2020
Risks of adverse events for users of proton-pump inhibitors plus aspirin or clopidogrel in patients with aspirin-related ulcer bleedingShih-Cheng Yang, Cheng-Kun Wu, Wei-Chen Tai, et al.
Medicine|July 19, 2016
Medical expenses in treating acute esophageal variceal bleeding: A 15-year nationwide population-based cohort studyChueh-Ling Liu, Cheng-Kun Wu, Hon-Yi Shi, et al.
Infectious Diseases and Therapy|May 3, 2023
The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled TrialWei-Chen Tai, Shih-Cheng Yang, Chih-Chien Yao, et al.
Therapeutic Advances in Gastroenterology|September 23, 2025
Comparative efficacy and safety of vonoprazan versus esomeprazole-based high-dose dual therapies for first-line <i>Helicobacter pylori</i> eradication: a randomized controlled trialWei-Chen Tai, Lung-Sheng Lu, Shih-Cheng Yang, et al.
Infection and Drug Resistance|June 17, 2021
Increased Risk of Pyogenic Liver Abscess after Endoscopic Sphincterotomy for Treatment of CholedocholithiasisCheng-Kun Wu, Chien-Ning Hsu, Wei-Ru Cho, et al.
Pageof 4